{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:33:21Z","timestamp":1791005601348,"version":"4.1.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["TTK22031652"],"award-info":[{"award-number":["TTK22031652"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001323","name":"Poliomyelitis Research Foundation","doi-asserted-by":"publisher","award":["23\/84"],"award-info":[{"award-number":["23\/84"]}],"id":[{"id":"10.13039\/501100001323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005274","name":"North-West University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005274","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The activity of HIV-1 and its viral proteins within the central nervous system (CNS) is responsible for a wide array of neuropathological effects, resulting in a spectrum of neurocognitive deficits defined as HIV-associated neurocognitive disorders (HAND). Amongst the various viral proteins, the transactivator of transcription (Tat) remains detectable even with effective antiretroviral therapy (ART) and suppressed viremia, highlighting the significance of this protein in the modern ART era. Tat has been extensively researched in both fundamental and clinical settings due to its role in neuroinflammation, neuronal damage, and neurocognitive impairment amongst people living with HIV (PLHIV). To date, numerous fundamental studies have explored Tat-induced neuroinflammation. However, there is no clear consensus on the most frequently studied inflammatory markers or the consistency in the levels of these Tat-induced inflammatory marker levels across different studies. Therefore, we conducted a scoping review of studies investigating Tat-induced neuroinflammation. We conducted searches in PubMed, Scopus, and Web of Science databases using a search protocol tailored specifically to adhere to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for scoping reviews (PRISMA-ScR) guidelines. From the 22 included studies, findings suggest that the HIV-1 Tat protein amplifies levels of neuroinflammatory markers. Amongst the vast array of inflammatory markers explored in the included studies, consistent results point to higher levels of CCL2, IL-6, IL-8, and TNF-\u03b1 in primary cells and cell lines exposed to or transfected with HIV-1 Tat. These markers are regulated by key inflammatory pathways, such as the extracellular\u00a0signal-regulated kinase (ERK)1\/2 mitogen-activated protein kinase (MAPK) pathway, the phosphatidylinositol 3-kinase (PI3K) pathway, the p38 MAPK pathway, and nuclear factor-kB (NF-kB). Furthermore, Tat has been shown to induce neuronal apoptosis, both directly and indirectly. With regards to study designs, utilizing full-length Tat101 at concentrations ranging from 100 to 1000 ng\/ml and durations of 24 and 48 h appears optimal for investigating Tat-induced neuroinflammation. In this context, we highlight specific inflammatory markers and pathways that are potentially pivotal in Tat-induced neuroinflammation and subsequent neuronal damage. A deeper investigation into these markers and pathways is crucial to better understand their roles in the development of HAND.<\/jats:p>","DOI":"10.1007\/s12035-024-04173-w","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T03:51:01Z","timestamp":1713325861000},"page":"9320-9346","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Transactivator of Transcription (Tat)-Induced Neuroinflammation as a Key Pathway in Neuronal Dysfunction: A Scoping Review"],"prefix":"10.1007","volume":"61","author":[{"given":"Tshengedzeni","family":"Muvenda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelia A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monray Edward","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"key":"4173_CR1","unstructured":"UNAIDS (2021) UNAIDS DATA 2021. Geneva: Joint United Nations Programme on HIV\/AIDS"},{"issue":"1","key":"4173_CR2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3390\/microorganisms11010221","volume":"11","author":"BM Nastri","year":"2023","unstructured":"Nastri BM, Pagliano P, Zannella C, Folliero V, Masullo A, Rinaldi L, Galdiero M, Franci G (2023) HIV and drug-resistant subtypes. Microorganisms 11(1):221","journal-title":"Microorganisms"},{"issue":"2","key":"4173_CR3","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.antiviral.2010.08.007","volume":"88","author":"ER de Arellano","year":"2010","unstructured":"de Arellano ER, Alcam\u00ed J, L\u00f3pez M, Soriano V, Holgu\u00edn \u00c1 (2010) Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants. Antivir Res 88(2):152\u2013159","journal-title":"Antivir Res"},{"issue":"3","key":"4173_CR4","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.molmed.2011.12.001","volume":"18","author":"J Hemelaar","year":"2012","unstructured":"Hemelaar J (2012) The origin and diversity of the HIV-1 pandemic. Trends Mol Med 18(3):182\u2013192. https:\/\/doi.org\/10.1016\/j.molmed.2011.12.001","journal-title":"Trends Mol Med"},{"issue":"15","key":"4173_CR5","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1056\/NEJMra0706737","volume":"358","author":"BS Taylor","year":"2008","unstructured":"Taylor BS, Sobieszczyk ME, McCutchan FE, Hammer SM (2008) The challenge of HIV-1 subtype diversity. N Engl J Med 358(15):1590\u20131602","journal-title":"N Engl J Med"},{"key":"4173_CR6","doi-asserted-by":"publisher","unstructured":"Gartner MJ, Roche M, Churchill MJ, Gorry PR, Flynn JK (2020) Understanding the mechanisms driving the spread of subtype C HIV-1. EBioMedicine 53:102682.\u00a0https:\/\/doi.org\/10.1016\/j.ebiom.2020.102682","DOI":"10.1016\/j.ebiom.2020.102682"},{"issue":"3","key":"4173_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/coh.0000000000000534","volume":"14","author":"N Bbosa","year":"2019","unstructured":"Bbosa N, Kaleebu P, Ssemwanga D (2019) HIV subtype diversity worldwide. Curr Opin HIV AIDS 14(3):153\u2013160. https:\/\/doi.org\/10.1097\/coh.0000000000000534","journal-title":"Curr Opin HIV AIDS"},{"issue":"2","key":"4173_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/s1473-3099(18)30647-9","volume":"19","author":"J Hemelaar","year":"2019","unstructured":"Hemelaar J, Elangovan R, Yun J, Dickson-Tetteh L, Fleminger I, Kirtley S, Williams B, Gouws-Williams E, Ghys PD (2019) Global and regional molecular epidemiology of HIV-1, 1990\u20132015: a systematic review, global survey, and trend analysis. Lancet Infect Dis 19(2):143\u2013155. https:\/\/doi.org\/10.1016\/s1473-3099(18)30647-9","journal-title":"Lancet Infect Dis"},{"key":"4173_CR9","doi-asserted-by":"publisher","unstructured":"Ojeda-Ju\u00e1rez D, Harahap-Carrillo IS, Kaul M (2023) Neurodegeneration Associated with HIV-1 in the Era of cART. In: Kostrzewa RM (ed) Handbook of Neurotoxicity. Springer International Publishing, Cham, pp 1999-2028. https:\/\/doi.org\/10.1007\/978-3-031-15080-7_137","DOI":"10.1007\/978-3-031-15080-7_137"},{"issue":"1","key":"4173_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nri1527","volume":"5","author":"F Gonz\u00e1lez-Scarano","year":"2005","unstructured":"Gonz\u00e1lez-Scarano F, Mart\u00edn-Garc\u00eda J (2005) The neuropathogenesis of AIDS. Nat Rev Immunol 5(1):69\u201381. https:\/\/doi.org\/10.1038\/nri1527","journal-title":"Nat Rev Immunol"},{"issue":"18","key":"4173_CR11","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","volume":"69","author":"A Antinori","year":"2007","unstructured":"Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69(18):1789\u20131799. https:\/\/doi.org\/10.1212\/01.WNL.0000287431.88658.8b","journal-title":"Neurology"},{"issue":"5","key":"4173_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nrneurol.2016.53","volume":"12","author":"D Saylor","year":"2016","unstructured":"Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, Mankowski JL, Brown A, Volsky DJ, McArthur JC (2016) HIV-associated neurocognitive disorder - pathogenesis and prospects for treatment. Nat Rev Neurol 12(5):309. https:\/\/doi.org\/10.1038\/nrneurol.2016.53","journal-title":"Nat Rev Neurol"},{"key":"4173_CR13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","volume":"17","author":"RK Heaton","year":"2011","unstructured":"Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, LeBlanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17:3\u201316","journal-title":"J Neurovirol"},{"issue":"11","key":"4173_CR14","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S1474-4422(14)70137-1","volume":"13","author":"S Nightingale","year":"2014","unstructured":"Nightingale S, Winston A, Letendre S, Michael BD, McArthur JC, Khoo S, Solomon T (2014) Controversies in HIV-associated neurocognitive disorders. Lancet Neurol 13(11):1139\u20131151","journal-title":"Lancet Neurol"},{"issue":"19","key":"4173_CR15","doi-asserted-by":"publisher","first-page":"e2610","DOI":"10.1212\/wnl.0000000000010752","volume":"95","author":"Y Wang","year":"2020","unstructured":"Wang Y, Liu M, Lu Q, Farrell M, Lappin JM, Shi J, Lu L, Bao Y (2020) Global prevalence and burden of HIV-associated neurocognitive disorder: a meta-analysis. Neurology 95(19):e2610\u2013e2621. https:\/\/doi.org\/10.1212\/wnl.0000000000010752","journal-title":"Neurology"},{"key":"4173_CR16","doi-asserted-by":"publisher","unstructured":"Agbey C, Avdoshina V, Mocchetti I (2023) Neuronal Cytoskeleton and HIV-Mediated Neurodegeneration. In: Kostrzewa RM (ed) Handbook of Neurotoxicity. Springer International Publishing, Cham, pp 2043-2058.\u00a0https:\/\/doi.org\/10.1007\/978-3-031-15080-7_230","DOI":"10.1007\/978-3-031-15080-7_230"},{"key":"4173_CR17","doi-asserted-by":"crossref","first-page":"104701","DOI":"10.1016\/j.nbd.2019.104701","volume":"136","author":"ME Williams","year":"2020","unstructured":"Williams ME, Zulu SS, Stein DJ, Joska JA, Naud\u00e9 PJ (2020) Signatures of HIV-1 subtype B and C Tat proteins and their effects in the neuropathogenesis of HIV-associated neurocognitive impairments. Neurobiol Dis 136:104701","journal-title":"Neurobiol Dis"},{"key":"4173_CR18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fnmol.2017.00163","volume":"10","author":"KT Gurwitz","year":"2017","unstructured":"Gurwitz KT, Burman RJ, Murugan BD, Garnett S, Ganief T, Soares NC, Raimondo JV, Blackburn JM (2017) Time-dependent, HIV-Tat-induced perturbation of human neurons in vitro: towards a model for the molecular pathology of HIV-associated neurocognitive disorders. Front Mol Neurosci 10:163","journal-title":"Front Mol Neurosci"},{"key":"4173_CR19","doi-asserted-by":"crossref","unstructured":"Nath A (2002) Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J Infect Dis 186(Supplement_2): S193-S198","DOI":"10.1086\/344528"},{"key":"4173_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/tra.12578","author":"AR Mele","year":"2018","unstructured":"Mele AR, Marino J, Chen K, Pirrone V, Janetopoulos C, Wigdahl B, Klase Z, Nonnemacher MR (2018) Defining the molecular mechanisms of HIV-1 Tat secretion: PtdIns(4,5)P(2) at the epicenter. Traffic. https:\/\/doi.org\/10.1111\/tra.12578","journal-title":"Traffic"},{"issue":"6","key":"4173_CR21","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1073\/pnas.95.6.3117","volume":"95","author":"K Conant","year":"1998","unstructured":"Conant K, Garzino-Demo A, Nath A, McArthur JC, Halliday W, Power C, Gallo RC, Major EO (1998) Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci USA 95(6):3117\u20133121. https:\/\/doi.org\/10.1073\/pnas.95.6.3117","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"4173_CR22","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s13365-022-01061-8","volume":"28","author":"IA Khan","year":"2022","unstructured":"Khan IA, Worrad AH, Singh MV, Maggirwar SB, Singh VB (2022) Human immunodeficiency virus-1 Tat exerts its neurotoxic effects by downregulating Sonic hedgehog signaling. J NeuroVirol 28(2):305\u2013311. https:\/\/doi.org\/10.1007\/s13365-022-01061-8","journal-title":"J NeuroVirol"},{"issue":"4","key":"4173_CR23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s13365-023-01151-1","volume":"29","author":"L Gao","year":"2023","unstructured":"Gao L, Sun W, Zhang D, Shang Y, Li L, Tao W, Zhang L, Liu H (2023) HIV-1 subtype B Tat enhances NOTCH3 signaling in astrocytes to mediate oxidative stress, inflammatory response, and neuronal apoptosis. J Neurovirol 29(4):479\u2013491. https:\/\/doi.org\/10.1007\/s13365-023-01151-1","journal-title":"J Neurovirol"},{"issue":"2","key":"4173_CR24","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1006\/viro.2002.1666","volume":"304","author":"E Acheampong","year":"2002","unstructured":"Acheampong E, Mukhtar M, Parveen Z, Ngoubilly N, Ahmad N, Patel C, Pomerantz RJ (2002) Ethanol strongly potentiates apoptosis induced by HIV-1 proteins in primary human brain microvascular endothelial cells. Virology 304(2):222\u2013234","journal-title":"Virology"},{"issue":"2","key":"4173_CR25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/13550280490279807","volume":"10","author":"TGD Aversa","year":"2004","unstructured":"Aversa TGD, Yu KO, Berman JW (2004) Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat. J Neurovirol 10(2):86\u201397","journal-title":"J Neurovirol"},{"issue":"3","key":"4173_CR26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/clim.2000.4905","volume":"96","author":"W Sheng","year":"2000","unstructured":"Sheng W, Hu S, Hegg C, Thayer SA, Peterson P (2000) Activation of human microglial cells by HIV-1 gp41 and Tat proteins. Clin Immunol 96(3):243\u2013251","journal-title":"Clin Immunol"},{"issue":"5","key":"4173_CR27","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.4049\/jimmunol.178.5.3226","volume":"178","author":"Z Sui","year":"2007","unstructured":"Sui Z, Sniderhan LF, Schifitto G, Phipps RP, Gelbard HA, Dewhurst S, Maggirwar SB (2007) Functional synergy between CD40 ligand and HIV-1 Tat contributes to inflammation: implications in HIV type 1 dementia. J Immunol 178(5):3226\u20133236","journal-title":"J Immunol"},{"key":"4173_CR28","doi-asserted-by":"publisher","unstructured":"Conant K, Garzino-Demo A, Nath A, McArthur JC, Halliday W, Power C, Gallo RC, Major EO (1998) Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci USA 95 (6):3117\u20133121.\u00a0https:\/\/doi.org\/10.1073\/pnas.95.6.3117","DOI":"10.1073\/pnas.95.6.3117"},{"issue":"4","key":"4173_CR29","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/jnc.12953","volume":"132","author":"M Tewari","year":"2015","unstructured":"Tewari M, Monika N, Varghese RK, Menon M, Seth P (2015) Astrocytes mediate HIV-1 Tat-induced neuronal damage via ligand-gated ion channel P2X7R. J Neurochem 132(4):464\u2013476","journal-title":"J Neurochem"},{"issue":"2","key":"4173_CR30","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3109\/13550281003735691","volume":"16","author":"A Khiati","year":"2010","unstructured":"Khiati A, Chaloin O, Muller S, Tardieu M, Horellou P (2010) Induction of monocyte chemoattractant protein-1 (MCP-1\/CCL2) gene expression by human immunodeficiency virus-1 Tat in human astrocytes is CDK9 dependent. J Neurovirol 16(2):150\u2013167","journal-title":"J Neurovirol"},{"issue":"1","key":"4173_CR31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/13550280490261699","volume":"10","author":"K Conant","year":"2004","unstructured":"Conant K, Hillaire CS, Anderson C, Galey D, Wang J, Nath A (2004) Human immunodeficiency virus type 1 Tat and methamphetamine affect the release and activation of matrix-degrading proteinases. J Neurovirol 10(1):21\u201328","journal-title":"J Neurovirol"},{"key":"4173_CR32","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s10875-008-9208-1","volume":"28","author":"SD Mahajan","year":"2008","unstructured":"Mahajan SD, Aalinkeel R, Sykes DE, Reynolds JL, Bindukumar B, Fernandez SF, Chawda R, Shanahan TC, Schwartz SA (2008) Tight junction regulation by morphine and HIV-1 tat modulates blood\u2013brain barrier permeability. J Clin Immunol 28:528\u2013541","journal-title":"J Clin Immunol"},{"issue":"5","key":"4173_CR33","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.4049\/jimmunol.163.5.2953","volume":"163","author":"JM Weiss","year":"1999","unstructured":"Weiss JM, Nath A, Major EO, Berman JW (1999) HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes. J Immunol 163(5):2953\u20132959","journal-title":"J Immunol"},{"issue":"3","key":"4173_CR34","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/ana.21292","volume":"63","author":"M Mishra","year":"2008","unstructured":"Mishra M, Vetrivel S, Siddappa NB, Ranga U, Seth P (2008) Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: significance of dicysteine C30C31 motif. Annals of neurology 63(3):366\u2013376","journal-title":"Annals of neurology"},{"issue":"8","key":"4173_CR35","doi-asserted-by":"crossref","first-page":"394","DOI":"10.5483\/BMBRep.2018.51.8.061","volume":"51","author":"H Jo","year":"2018","unstructured":"Jo H, Jang HY, Youn GS, Kim D, Lee CY, Jang JH, Choi SY, Jun J-G, Park J (2018) Hindsiipropane B alleviates HIV-1 Tat-induced inflammatory responses by suppressing HDAC6-NADPH oxidase-ROS axis in astrocytes. BMB Rep 51(8):394","journal-title":"BMB Rep"},{"issue":"2","key":"4173_CR36","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3858\/emm.2009.41.2.011","volume":"41","author":"SM Ju","year":"2009","unstructured":"Ju SM, Song HY, Lee J, Lee SJ, Choi SY, Park J (2009) Extracellular HIV-1 Tat up-regulates expression of matrix metalloproteinase-9 via a MAPK-NF-\u03baB dependent pathway in human astrocytes. Exp Mol Med 41(2):86\u201393","journal-title":"Exp Mol Med"},{"issue":"24","key":"4173_CR37","doi-asserted-by":"crossref","first-page":"17098","DOI":"10.1074\/jbc.274.24.17098","volume":"274","author":"A Nath","year":"1999","unstructured":"Nath A, Conant K, Chen P, Scott C, Major EO (1999) Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes: a hit and run phenomenon. J Biol Chem 274(24):17098\u201317102","journal-title":"J Biol Chem"},{"issue":"2","key":"4173_CR38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/13550280701258399","volume":"13","author":"LA Boven","year":"2007","unstructured":"Boven LA, Noorbakhsh F, Bouma G, van der Zee R, Vargas DL, Pardo C, McArthur JC, Nottet HS, Power C (2007) Brain-derived human immunodeficiency virus-1 Tat exerts differential effects on LTR transactivation and neuroimmune activation. J Neurovirol 13(2):173\u2013184","journal-title":"J Neurovirol"},{"key":"4173_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-014-0214-3","volume":"11","author":"AR Nookala","year":"2014","unstructured":"Nookala AR, Kumar A (2014) Molecular mechanisms involved in HIV-1 Tat-mediated induction of IL-6 and IL-8 in astrocytes. J Neuroinflammation 11:1\u201318","journal-title":"J Neuroinflammation"},{"issue":"11","key":"4173_CR40","doi-asserted-by":"crossref","first-page":"e78855","DOI":"10.1371\/journal.pone.0078855","volume":"8","author":"AR Nookala","year":"2013","unstructured":"Nookala AR, Shah A, Noel RJ, Kumar A (2013) HIV-1 Tat-mediated induction of CCL5 in astrocytes involves NF-\u03baB, AP-1, C\/EBP\u03b1 and C\/EBP\u03b3 transcription factors and JAK, PI3K\/Akt and p38 MAPK signaling pathways. PloS one 8(11):e78855","journal-title":"PloS one"},{"issue":"3","key":"4173_CR41","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s13365-023-01131-5","volume":"29","author":"X Qiu","year":"2023","unstructured":"Qiu X, Wang J, Zhang W, Duan C, Chen T, Zhang D, Su J, Gao L (2023) Disruption of the ADAM17\/NF-\u03baB feedback loop in astrocytes ameliorates HIV-1 Tat-induced inflammatory response and neuronal death. J Neurovirol 29(3):283\u2013296. https:\/\/doi.org\/10.1007\/s13365-023-01131-5","journal-title":"J Neurovirol"},{"issue":"19","key":"4173_CR42","doi-asserted-by":"crossref","first-page":"9214","DOI":"10.1128\/JVI.74.19.9214-9221.2000","volume":"74","author":"O Kutsch","year":"2000","unstructured":"Kutsch O, Oh J-W, Nath A, Benveniste E (2000) Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes. J Virol 74(19):9214\u20139221","journal-title":"J Virol"},{"issue":"3\u20134","key":"4173_CR43","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000026336","volume":"5","author":"M Mayne","year":"1998","unstructured":"Mayne M, Bratanich AC, Chen P, Rana F, Nath A, Power C (1998) HIV-1 Tat molecular diversity and induction of TNF-\u03b1: implications for HIV-induced neurological disease. Neuroimmunomodulation 5(3\u20134):184\u2013192","journal-title":"Neuroimmunomodulation"},{"issue":"5","key":"4173_CR44","doi-asserted-by":"crossref","first-page":"e5709","DOI":"10.1371\/journal.pone.0005709","volume":"4","author":"R Williams","year":"2009","unstructured":"Williams R, Yao H, Dhillon NK, Buch SJ (2009) HIV-1 Tat co-operates with IFN-\u03b3 and TNF-\u03b1 to increase CXCL10 in human astrocytes. PLoS One 4(5):e5709","journal-title":"PLoS One"},{"issue":"140","key":"4173_CR45","first-page":"55","volume":"22","author":"R Likert","year":"1932","unstructured":"Likert R (1932) A technique for the measurement of attitudes. Arch Sci Psychol 22(140):55\u201355","journal-title":"Arch Sci Psychol"},{"issue":"3","key":"4173_CR46","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","volume":"22","author":"ML McHugh","year":"2012","unstructured":"McHugh ML (2012) Interrater reliability: the kappa statistic. Biochem Med (Zagreb) 22(3):276\u2013282","journal-title":"Biochem Med (Zagreb)"},{"issue":"2","key":"4173_CR47","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/13550280701258399","volume":"13","author":"LA Boven","year":"2007","unstructured":"Boven LA, Noorbakhsh F, Bouma G, van der Zee R, Vargas DL, Pardo C, McArthur JC, Nottet HS, Power C (2007) Brain-derived human immunodeficiency virus-1 Tat exerts differential effects on LTR transactivation and neuroimmune activation. J Neurovirol 13(2):173\u2013184. https:\/\/doi.org\/10.1080\/13550280701258399","journal-title":"J Neurovirol"},{"issue":"19","key":"4173_CR48","doi-asserted-by":"publisher","first-page":"9214","DOI":"10.1128\/jvi.74.19.9214-9221.2000","volume":"74","author":"O Kutsch","year":"2000","unstructured":"Kutsch O, Oh J, Nath A, Benveniste EN (2000) Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes. J Virol 74(19):9214\u20139221. https:\/\/doi.org\/10.1128\/jvi.74.19.9214-9221.2000","journal-title":"J Virol"},{"issue":"3\u20134","key":"4173_CR49","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000026336","volume":"5","author":"M Mayne","year":"1998","unstructured":"Mayne M, Bratanich AC, Chen P, Rana F, Nath A, Power C (1998) HIV-1 tat molecular diversity and induction of TNF-alpha: implications for HIV-induced neurological disease. Neuroimmunomodulation 5(3\u20134):184\u2013192. https:\/\/doi.org\/10.1159\/000026336","journal-title":"Neuroimmunomodulation"},{"issue":"5","key":"4173_CR50","doi-asserted-by":"publisher","first-page":"e5709","DOI":"10.1371\/journal.pone.0005709","volume":"4","author":"R Williams","year":"2009","unstructured":"Williams R, Yao H, Dhillon NK, Buch SJ (2009) HIV-1 Tat co-operates with IFN-gamma and TNF-alpha to increase CXCL10 in human astrocytes. PLoS One 4(5):e5709. https:\/\/doi.org\/10.1371\/journal.pone.0005709","journal-title":"PLoS One"},{"issue":"8","key":"4173_CR51","doi-asserted-by":"publisher","first-page":"394","DOI":"10.5483\/bmbrep.2018.51.8.061","volume":"51","author":"H Jo","year":"2018","unstructured":"Jo H, Jang HY, Youn GS, Kim D, Lee CY, Jang JH, Choi SY, Jun JG, Park J (2018) Hindsiipropane B alleviates HIV-1 Tat-induced inflammatory responses by suppressing HDAC6-NADPH oxidase-ROS axis in astrocytes. BMB Rep 51(8):394\u2013399. https:\/\/doi.org\/10.5483\/bmbrep.2018.51.8.061","journal-title":"BMB Rep"},{"issue":"2","key":"4173_CR52","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3109\/13550281003735691","volume":"16","author":"A Khiati","year":"2010","unstructured":"Khiati A, Chaloin O, Muller S, Tardieu M, Horellou P (2010) Induction of monocyte chemoattractant protein-1 (MCP-1\/CCL2) gene expression by human immunodeficiency virus-1 Tat in human astrocytes is CDK9 dependent. J Neurovirol 16(2):150\u2013167. https:\/\/doi.org\/10.3109\/13550281003735691","journal-title":"J Neurovirol"},{"issue":"3","key":"4173_CR53","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/ana.21292","volume":"63","author":"M Mishra","year":"2008","unstructured":"Mishra M, Vetrivel S, Siddappa NB, Ranga U, Seth P (2008) Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: significance of dicysteine C30C31 motif. Ann Neurol 63(3):366\u2013376. https:\/\/doi.org\/10.1002\/ana.21292","journal-title":"Ann Neurol"},{"issue":"5","key":"4173_CR54","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.4049\/jimmunol.163.5.2953","volume":"163","author":"JM Weiss","year":"1999","unstructured":"Weiss JM, Nath A, Major EO, Berman JW (1999) HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes. J Immunol 163(5):2953\u20132959","journal-title":"J Immunol"},{"issue":"2","key":"4173_CR55","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1006\/viro.2002.1666","volume":"304","author":"E Acheampong","year":"2002","unstructured":"Acheampong E, Mukhtar M, Parveen Z, Ngoubilly N, Ahmad N, Patel C, Pomerantz RJ (2002) Ethanol strongly potentiates apoptosis induced by HIV-1 proteins in primary human brain microvascular endothelial cells. Virology 304(2):222\u2013234. https:\/\/doi.org\/10.1006\/viro.2002.1666","journal-title":"Virology"},{"issue":"1","key":"4173_CR56","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/13550280490261699","volume":"10","author":"K Conant","year":"2004","unstructured":"Conant K, St Hillaire C, Anderson C, Galey D, Wang J, Nath A (2004) Human immunodeficiency virus type 1 Tat and methamphetamine affect the release and activation of matrix-degrading proteinases. J Neurovirol 10(1):21\u201328. https:\/\/doi.org\/10.1080\/13550280490261699","journal-title":"J Neurovirol"},{"key":"4173_CR57","doi-asserted-by":"publisher","unstructured":"Asia LK, Jansen Van Vuren E, Williams ME (2022) The influence of viral protein R amino acid substitutions on clinical outcomes in people living with HIV: a systematic review. Eur J Clin Invest e13943. https:\/\/doi.org\/10.1111\/eci.13943","DOI":"10.1111\/eci.13943"},{"key":"4173_CR58","doi-asserted-by":"publisher","first-page":"577649","DOI":"10.1016\/j.jneuroim.2021.577649","volume":"358","author":"ME Williams","year":"2021","unstructured":"Williams ME, Stein DJ, Joska JA, Naud\u00e9 PJW (2021) Cerebrospinal fluid immune markers and HIV-associated neurocognitive impairments: a systematic review. J Neuroimmunol 358:577649. https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577649","journal-title":"J Neuroimmunol"},{"issue":"6","key":"4173_CR59","doi-asserted-by":"crossref","first-page":"e2516","DOI":"10.1371\/journal.pone.0002516","volume":"3","author":"P Ancuta","year":"2008","unstructured":"Ancuta P, Kamat A, Kunstman KJ, Kim E-Y, Autissier P, Wurcel A, Zaman T, Stone D, Mefford M, Morgello S (2008) Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PloS one 3(6):e2516","journal-title":"PloS one"},{"issue":"1\u20132","key":"4173_CR60","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jneuroim.2010.11.006","volume":"233","author":"RA Cohen","year":"2011","unstructured":"Cohen RA, de la Monte S, Gongvatana A, Ombao H, Gonzalez B, Devlin KN, Navia B, Tashima KT (2011) Plasma cytokine concentrations associated with HIV\/hepatitis C coinfection are related to attention, executive and psychomotor functioning. J Neuroimmunol 233(1\u20132):204\u2013210","journal-title":"J Neuroimmunol"},{"issue":"4","key":"4173_CR61","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/01.wnn.0000213916.10514.57","volume":"19","author":"Woods SP, Morgan EE, Marquie-Beck J, Carey CL, Grant I, Letendre SL, Group HNRC","year":"2006","unstructured":"Woods SP, Morgan EE, Marquie-Beck J, Carey CL, Grant I, Letendre SL, Group HNRC (2006) Markers of macrophage activation and axonal injury are associated with prospective memory in HIV-1 disease. Cogn Behav Neurol 19(4):217\u2013221","journal-title":"Cogn Behav Neurol"},{"key":"4173_CR62","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s13365-013-0150-5","volume":"19","author":"L Yuan","year":"2013","unstructured":"Yuan L, Qiao L, Wei F, Yin J, Liu L, Ji Y, Smith D, Li N, Chen D (2013) Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China. J Neurovirol 19:144\u2013149","journal-title":"J Neurovirol"},{"key":"4173_CR63","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbi.2017.04.024","volume":"65","author":"Y Xing","year":"2017","unstructured":"Xing Y, Shepherd N, Lan J, Li W, Rane S, Gupta SK, Zhang S, Dong J, Yu Q (2017) MMPs\/TIMPs imbalances in the peripheral blood and cerebrospinal fluid are associated with the pathogenesis of HIV-1-associated neurocognitive disorders. Brain Behav Immun 65:161\u2013172","journal-title":"Brain Behav Immun"},{"issue":"4","key":"4173_CR64","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1523\/JNEUROSCI.3863-05.2006","volume":"26","author":"EA Eugenin","year":"2006","unstructured":"Eugenin EA, Osiecki K, Lopez L, Goldstein H, Calderon TM, Berman JW (2006) CCL2\/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood\u2013brain barrier: a potential mechanism of HIV\u2013CNS invasion and NeuroAIDS. J Neurosci 26(4):1098\u20131106","journal-title":"J Neurosci"},{"issue":"1","key":"4173_CR65","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.1038\/s41598-023-33491-7","volume":"13","author":"B-H Kim","year":"2023","unstructured":"Kim B-H, Hadas E, Kelschenbach J, Chao W, Gu C-J, Potash MJ, Volsky DJ (2023) CCL2 is required for initiation but not persistence of HIV infection mediated neurocognitive disease in mice. Sci Rep 13(1):6577","journal-title":"Sci Rep"},{"key":"4173_CR66","doi-asserted-by":"crossref","first-page":"104689","DOI":"10.1016\/j.psyneuen.2020.104689","volume":"118","author":"ME Williams","year":"2020","unstructured":"Williams ME, Ipser JC, Stein DJ, Joska JA, Naud\u00e9 PJ (2020) Peripheral immune dysregulation in the ART era of HIV-associated neurocognitive impairments: a systematic review. Psychoneuroendocrinology 118:104689","journal-title":"Psychoneuroendocrinology"},{"key":"4173_CR67","doi-asserted-by":"crossref","first-page":"577649","DOI":"10.1016\/j.jneuroim.2021.577649","volume":"358","author":"ME Williams","year":"2021","unstructured":"Williams ME, Stein DJ, Joska JA, Naud\u00e9 PJ (2021) Cerebrospinal fluid immune markers and HIV-associated neurocognitive impairments: a systematic review. J Neuroimmunol 358:577649","journal-title":"J Neuroimmunol"},{"issue":"1","key":"4173_CR68","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/1742-2094-9-131","volume":"9","author":"R Mishra","year":"2012","unstructured":"Mishra R, Chhatbar C, Singh SK (2012) HIV-1 Tat C-mediated regulation of tumor necrosis factor receptor-associated factor-3 by microRNA 32 in human microglia. J Neuroinflammation 9(1):131. https:\/\/doi.org\/10.1186\/1742-2094-9-131","journal-title":"J Neuroinflammation"},{"key":"4173_CR69","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/BF03401633","volume":"2","author":"GJ Nuovo","year":"1996","unstructured":"Nuovo GJ, Alfieri ML, Cerami A (1996) AIDS dementia is associated with massive, activated HIV-1 infection and concomitant expression of several cytokines. Mol Med 2:358\u2013366","journal-title":"Mol Med"},{"issue":"43","key":"4173_CR70","doi-asserted-by":"crossref","first-page":"22830","DOI":"10.1074\/jbc.M116.731836","volume":"291","author":"Y Fan","year":"2016","unstructured":"Fan Y, He JJ (2016) HIV-1 tat promotes lysosomal exocytosis in astrocytes and contributes to astrocyte-mediated tat neurotoxicity. J Biol Chem 291(43):22830\u201322840","journal-title":"J Biol Chem"},{"issue":"1","key":"4173_CR71","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1742-2094-9-115","volume":"9","author":"B Stansley","year":"2012","unstructured":"Stansley B, Post J, Hensley K (2012) A comparative review of cell culture systems for the study of microglial biology in Alzheimer\u2019s disease. J Neuroinflammation 9(1):115. https:\/\/doi.org\/10.1186\/1742-2094-9-115","journal-title":"J Neuroinflammation"},{"issue":"4","key":"4173_CR72","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1177\/0271678X16656199","volume":"37","author":"Y Du","year":"2017","unstructured":"Du Y, Deng W, Wang Z, Ning M, Zhang W, Zhou Y, Lo EH, Xing C (2017) Differential subnetwork of chemokines\/cytokines in human, mouse, and rat brain cells after oxygen\u2013glucose deprivation. J Cereb Blood Flow Metab 37(4):1425\u20131434","journal-title":"J Cereb Blood Flow Metab"},{"issue":"9","key":"4173_CR73","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1177\/24725552211030903","volume":"26","author":"O Jung","year":"2021","unstructured":"Jung O, Song MJ, Ferrer M (2021) Operationalizing the use of biofabricated tissue models as preclinical screening platforms for drug discovery and development. SLAS Discov 26(9):1164\u20131176. https:\/\/doi.org\/10.1177\/24725552211030903","journal-title":"SLAS Discov"},{"key":"4173_CR74","doi-asserted-by":"publisher","unstructured":"Mayer T, Jagla B, Wyler MR, Kelly PD, Aulner N, Beard M, Barger G, T\u00f6bben U, Smith DH, Brand\u00e9n L, Rothman JE (2006) [15] - Cell\u2010based assays using primary endothelial cells to study multiple steps in inflammation. In: Inglese J (ed) Methods in enzymology, vol 414. Academic Press, pp 266-283. https:\/\/doi.org\/10.1016\/S0076-6879(06)14015-X","DOI":"10.1016\/S0076-6879(06)14015-X"},{"issue":"1","key":"4173_CR75","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12974-019-1466-8","volume":"16","author":"F Zhou","year":"2019","unstructured":"Zhou F, Liu X, Gao L, Zhou X, Cao Q, Niu L, Wang J, Zuo D, Li X, Yang Y, Hu M, Yu Y, Tang R, Lee BH, Choi BW, Wang Y, Izumiya Y, Xue M, Zheng K, Gao D (2019) HIV-1 Tat enhances purinergic P2Y4 receptor signaling to mediate inflammatory cytokine production and neuronal damage via PI3K\/Akt and ERK MAPK pathways. J Neuroinflammation 16(1):71. https:\/\/doi.org\/10.1186\/s12974-019-1466-8","journal-title":"J Neuroinflammation"},{"issue":"1","key":"4173_CR76","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.taap.2014.07.010","volume":"280","author":"GS Youn","year":"2014","unstructured":"Youn GS, Kwon D-J, Ju SM, Rhim H, Bae YS, Choi SY, Park J (2014) Celastrol ameliorates HIV-1 Tat-induced inflammatory responses via NF-kappaB and AP-1 inhibition and heme oxygenase-1 induction in astrocytes. Toxicol Appl Pharmacol 280(1):42\u201352","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"4173_CR77","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1046\/j.1471-4159.2001.00511.x","volume":"78","author":"AJ Bruce-Keller","year":"2001","unstructured":"Bruce-Keller AJ, Barger SW, Moss NI, Pham JT, Keller JN, Nath A (2001) Pro-inflammatory and pro-oxidant properties of the HIV protein Tat in a microglial cell line: attenuation by 17\u03b2-estradiol. J Neurochem 78(6):1315\u20131324","journal-title":"J Neurochem"},{"issue":"2","key":"4173_CR78","doi-asserted-by":"crossref","first-page":"76","DOI":"10.24875\/AIDSRev.19000051","volume":"21","author":"M Santerre","year":"2019","unstructured":"Santerre M, Wang Y, Arjona S, Allen C, Sawaya BE (2019) Differential contribution of HIV-1 subtypes B and C to neurological disorders: mechanisms and possible treatments. AIDS Rev 21(2):76","journal-title":"AIDS Rev"},{"issue":"1","key":"4173_CR79","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1038\/s41598-019-39531-5","volume":"9","author":"AP Ruiz","year":"2019","unstructured":"Ruiz AP, Ajasin DO, Ramasamy S, DesMarais V, Eugenin EA, Prasad VR (2019) A naturally occurring polymorphism in the HIV-1 tat basic domain inhibits uptake by bystander cells and leads to reduced neuroinflammation. Sci Rep 9(1):3308","journal-title":"Sci Rep"},{"key":"4173_CR80","doi-asserted-by":"crossref","first-page":"866611","DOI":"10.3389\/fmicb.2022.866611","volume":"13","author":"ME Williams","year":"2022","unstructured":"Williams ME, Cloete R (2022) Molecular modeling of subtype-specific Tat protein signatures to predict Tat-TAR interactions that may be involved in HIV-associated neurocognitive disorders. Front Microbiol 13:866611","journal-title":"Front Microbiol"},{"key":"4173_CR81","doi-asserted-by":"publisher","unstructured":"de Almeida SM, Beltrame MP, Tang B, Rotta I, Abramson I, Vaida F, Schrier R, Ellis RJ (2023) Cerebrospinal fluid CD14(++)CD16(+) monocytes in HIV-1 subtype C compared with subtype B. J Neurovirol 29 (3):308\u2013324. https:\/\/doi.org\/10.1007\/s13365-023-01137-z","DOI":"10.1007\/s13365-023-01137-z"},{"key":"4173_CR82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12993-015-0083-7","volume":"11","author":"J Dara","year":"2015","unstructured":"Dara J, Dow A, Cromwell E, Sturdevant CB, Mallewa M, Swanstrom R, Van Rie A, Prasad VR (2015) Multivariable analysis to determine if HIV-1 Tat dicysteine motif is associated with neurodevelopmental delay in HIV-infected children in Malawi. Behav Brain Funct 11:1\u20138","journal-title":"Behav Brain Funct"},{"key":"4173_CR83","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3389\/fmicb.2020.00444","volume":"11","author":"AR Mele","year":"2020","unstructured":"Mele AR, Marino J, Dampier W, Wigdahl B, Nonnemacher MR (2020) HIV-1 Tat length: comparative and functional considerations. Front Microbiol 11:444. https:\/\/doi.org\/10.3389\/fmicb.2020.00444","journal-title":"Front Microbiol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04173-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04173-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04173-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T11:07:26Z","timestamp":1729595246000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04173-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":83,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["4173"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04173-w","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,17]]},"assertion":[{"value":"23 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}